These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6811918)

  • 1. Methodology for assessing agents that suppress methadone withdrawal: a study of baclofen.
    Jaffe JH; Kanzler M; Brady R; Friedman L
    NIDA Res Monogr; 1982 Apr; 41():269-75. PubMed ID: 6811918
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study of a Neuro-Stimulator Device vs. methadone in alleviating opiate withdrawal symptoms.
    Elmoghazy E; Johnson BD; Alling FA
    NIDA Res Monogr; 1989; 95():388-9. PubMed ID: 2701306
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone withdrawal psychosis.
    Levinson I; Galynker II; Rosenthal RN
    J Clin Psychiatry; 1995 Feb; 56(2):73-6. PubMed ID: 7852256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baclofen-assisted detoxification from opiates. A pilot study.
    Krystal JH; McDougle CJ; Kosten TR; Price LH; Aghajanian GK; Charney DS
    J Subst Abuse Treat; 1992; 9(2):139-42. PubMed ID: 1324986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-administration of clonidine and oxazepam by methadone detoxification patients.
    Preston KL; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1984 Mar; 49():192-8. PubMed ID: 6434959
    [No Abstract]   [Full Text] [Related]  

  • 8. Lofexidine blocks acute opiate withdrawal.
    Gold MS; Pottash AC; Sweeney DR; Extein I; Annitto WJ
    NIDA Res Monogr; 1982 Apr; 41():264-8. PubMed ID: 6811917
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of opioid withdrawal].
    Shaygani S; Waal H
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):114-5. PubMed ID: 19151804
    [No Abstract]   [Full Text] [Related]  

  • 10. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-regulated opioid detoxification by humans: effects of methadone pretreatment.
    McLeod DR; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1982 Apr; 41():232-8. PubMed ID: 6811914
    [No Abstract]   [Full Text] [Related]  

  • 12. Metyrapone-induced withdrawal symptoms: symptoms in methadone-maintained patients.
    Kennedy JA; Hartman N; Sbriglio R; Khuri E; Albeck H; Kreek MJ
    NIDA Res Monogr; 1990; 105():416. PubMed ID: 1876057
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
    Newcombe DA; Bochner F; White JM; Somogyi AA
    Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone-nicotine interactions in methadone maintenance treatment patients.
    Elkader AK; Brands B; Selby P; Sproule BA
    J Clin Psychopharmacol; 2009 Jun; 29(3):231-8. PubMed ID: 19440076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Depressive disorders in management of drug dependent patients. Methadone maintenance].
    Laqueille X; Spadone C
    Encephale; 1995 Dec; 21 Spec No 4():11-4. PubMed ID: 8808339
    [No Abstract]   [Full Text] [Related]  

  • 17. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
    Titievsky J; Seco G; Barranco M; Kyle EM
    J Clin Psychiatry; 1982 Nov; 43(11):454-6. PubMed ID: 7174622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone.
    Jones HE; Johnson RE; Jasinski DR; Milio L
    Drug Alcohol Depend; 2005 Apr; 78(1):33-8. PubMed ID: 15769555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy.
    Eder H; Jagsch R; Kraigher D; Primorac A; Ebner N; Fischer G
    Addiction; 2005 Aug; 100(8):1101-9. PubMed ID: 16042640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.